Work

Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer

Year: 2016

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.2236

Authors: Pei Ni Ding, Sarah J. Lord, Val Gebski, Matthew Links, Victoria Bray, Richard J. Gralla, James Chih-Hsin Yang, Chee Khoon Lee

Institutions: The University of Sydney, Liverpool Hospital, National Health and Medical Research Council, The University of Notre Dame Australia, St George Hospital, Albert Einstein College of Medicine, Jacobi Medical Center, National Taiwan University, National Taiwan University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2562380622

FWCI: 2.252

Cites: 33

Cited by: 172

Related to: 10